\-\ Texto\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ bilateral\\ epididymal\\ masses\ \(0\)\
\-\ cystic\\ and\\ solid\\ heterogeneous\ \(1\)\
\-\ systemic\\ disease\ \(10\)\
\-\ inflammatory\\ vs\\.\\ neoplastic\ \(1\)\
\-\ \\â\\€\\¢\\ pancreatic\\ and\\ renal\\ masses\ \(0\)\
\-\ heterogeneous\ \(357\)\
\-\ systemic\\ disease\ \(10\)\
\-\ epididymal\\ cystadenomas\\,\\ von\\ hippel\\-lindau\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ von\\ hippel\\-lindau\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ von\\ hippel\\-lindau\\ syndrome\ \(0\)\
\-\ \\â\\€\\¢\\ chromosome\\ 3\\ disease\ \(0\)\
\-\ 31\\ y\\.o\\.\\ man\\ with\\ bilateral\\ scrotal\\ masses\\.\\ \\ pmh\\ of\\ previous\\ resection\\ of\\ bilateral\\ adrenal\\ masses\\.\ \(0\)\
\-\ epididymal\\ cystadenomas\\ \\(eca\\)\\ are\\ uncommon\\ tumors\\ that\\,\\ even\\ as\\ sporadic\\ lesions\\,\\ are\\ associated\\ with\\ a\\ somatic\\ mutation\\ in\\ the\\ vhl\\ gene\\ on\\ chromosome\\ 3\\.\\ \\ in\\ von\\-hippel\\ lindau\\ disease\\ \\(vhl\\)\\ patients\\,\\ there\\ is\\ a\\ germ\\-line\\ mutation\\ in\\ the\\ vhl\\ gene\\,\\ affecting\\ every\\ cell\\ in\\ the\\ patient\\'s\\ body\\.\\ \\ the\\ presence\\ of\\ bilateral\\ epididymal\\ lesions\\ suggests\\ a\\ germline\\ systemic\\ mutation\\,\\ rather\\ than\\ a\\ local\\ somatic\\ mutation\\.\\ \\ of\\ course\\,\\ the\\ additional\\ findings\\ of\\ the\\ lesions\\ in\\ the\\ kidney\\ and\\ pancreas\\ provide\\ further\\ evidence\\ of\\ the\\ systemic\\ disease\\ \\-\\ von\\ hippel\\ lindau\\ disease\\.\ \(0\)\
\-\ vhl\\ was\\ originally\\ described\\ as\\ the\\ familial\\ association\\ of\\ multiple\\ vascular\\ \\"angiomas\\"\\ of\\ the\\ retina\\ \\(von\\ hippel\\ disease\\)\\ with\\ hemangioblastomas\\ \\(the\\ lindau\\ tumor\\)\\.\\ \\ however\\,\\ it\\ was\\ shortly\\ recognized\\ that\\ these\\ patients\\ had\\ a\\ more\\ complex\\ systemic\\ disease\\ with\\ lesions\\ affecting\\ the\\ solid\\ abdominal\\ organs\\ \\(kidney\\ and\\ pancreas\\)\\ with\\ cysts\\ and\\ both\\ benign\\ and\\ malignant\\ neoplasms\\.\\ \\ unlike\\ the\\ \\"classic\\"\\ phakomatoses\\,\\ vhl\\ is\\ not\\ associated\\ with\\ cutaneous\\ findings\\.\\ \\ vhl\\ is\\ autosomal\\ dominant\\,\\ without\\ racial\\ or\\ sexual\\ predilection\\.\\ \\ the\\ responsible\\ gene\\ has\\ been\\ identified\\ on\\ chromosome\\ 3p\\,\\ and\\ the\\ prevalence\\ is\\ estimated\\ at\\ about\\ 1\\/35\\,000\\ to\\ 1\\/50\\,000\\ people\\ in\\ the\\ united\\ states\\.\ \(0\)\
\-\ the\\ study\\ group\\ at\\ the\\ nih\\ has\\ suggested\\ subclassifying\\ vhl\\ into\\ 3\\ subtypes\\.\\ \\ the\\ most\\ frequent\\ is\\ type\\ i\\,\\ vhl\\ without\\ pheochromocytoma\\.\\ \\ these\\ patients\\ have\\ the\\ \\"classic\\"\\ features\\ of\\ renal\\ and\\ pancreatic\\ cysts\\,\\ and\\ a\\ high\\ risk\\ for\\ developing\\ renal\\ cell\\ carcinoma\\ \\(rcc\\)\\.\ \(0\)\
\-\ type\\ ii\\ is\\ vhl\\ with\\ pheochromocytoma\\,\\ and\\ it\\ is\\ further\\ divided\\ into\\ iia\\ and\\ iib\\.\\ \\ type\\ iia\\ has\\ pancreatic\\ islet\\ cell\\ tumors\\ \\(typically\\ without\\ cysts\\)\\ and\\ iib\\ has\\ both\\ renal\\ and\\ pancreatic\\ disease\\.\ \(0\)\
\-\ this\\ patient\\ has\\ evidence\\ of\\ previous\\ adrenal\\ surgery\\,\\ and\\ has\\ both\\ pancreatic\\ and\\ renal\\ cysts\\.\\ \\ so\\ this\\ is\\ type\\ iib\\.\ \(0\)\
\-\ more\\ than\\ half\\ of\\ these\\ patients\\ will\\ develop\\ or\\ present\\ with\\ retinal\\ angiomas\\.\\ \\ these\\ are\\ actually\\ hemangioblastomas\\ of\\ the\\ retina\\,\\ and\\ cause\\ retinal\\ hemorrhage\\ and\\ detachment\\.\\ \\ two\\-thirds\\ or\\ more\\ of\\ vhl\\ patients\\ will\\ have\\ hemangioblastomas\\,\\ usually\\ infratentorial\\,\\ with\\ the\\ cerebellum\\ by\\ far\\ the\\ most\\ common\\ site\\.\\ \\ although\\ the\\ hemangioblastoma\\ is\\ a\\ benign\\ nonglial\\ neoplasm\\,\\ it\\ is\\ hypervascular\\,\\ and\\ may\\ recur\\ if\\ incompletely\\ resected\\.\\ \\ in\\ addition\\,\\ patients\\ with\\ vhl\\ are\\ prone\\ to\\ develop\\ multiple\\ hemangioblastomas\\,\\ that\\ may\\ be\\ present\\ simultaneously\\ or\\ may\\ appear\\ as\\ metachronous\\ \\(asynchronous\\)\\ lesions\\.\ \(0\)\
\-\ as\\ this\\ patient\\ illustrates\\,\\ the\\ epididymis\\ may\\ develop\\ benign\\ cystadenomas\\.\\ \\ the\\ presence\\ of\\ multiple\\ lesions\\ should\\ always\\ suggest\\ a\\ systemic\\ disease\\.\\ \\ systemic\\ diseases\\ may\\ be\\ congenital\\ \\(maldevelopmental\\ and\\ genetic\\)\\,\\ inflammatory\\ \\(infectious\\,\\ autoimmune\\,\\ etc\\.\\)\\,\\ toxic\\,\\ metabolic\\,\\ and\\ dissemination\\ of\\ a\\ neoplasm\\ \\(metastasis\\)\\.\\ \\ hematogenous\\ dissemination\\ of\\ neoplasms\\ and\\ infection\\ may\\ create\\ multiple\\ and\\ often\\ bilateral\\ lesions\\,\\ but\\ they\\ are\\ usually\\ located\\ in\\ asymmetric\\ and\\ somewhat\\ random\\ patterns\\.\\ \\ however\\,\\ toxic\\,\\ metabolic\\ and\\ genetic\\ lesions\\ may\\ show\\ anatomic\\ distributions\\ of\\ lesions\\ that\\ may\\ be\\ bilateral\\ and\\ can\\ be\\ strikingly\\ symmetric\\.\ \(0\)\
\-\ in\\ the\\ differential\\ diagnosis\\ of\\ this\\ case\\,\\ the\\ presence\\ of\\ bilateral\\ masses\\ of\\ the\\ scrotum\\ could\\ have\\ been\\ inflammatory\\ or\\ infectious\\.\\ \\ however\\,\\ the\\ localization\\ of\\ these\\ masses\\ with\\ anatomic\\ symmetry\\ within\\ the\\ epididymis\\,\\ might\\ suggest\\ consideration\\ of\\ a\\ syndrome\\.\\ \\ in\\ addition\\,\\ the\\ morphology\\ of\\ the\\ masses\\ as\\ heterogeneously\\ solid\\ and\\ cystic\\ also\\ suggests\\ the\\ specific\\ diagnosis\\ of\\ a\\ cystadenoma\\.\\ \\ these\\ two\\ clues\\ fit\\ together\\ well\\ if\\ the\\ patient\\ has\\ von\\ hippel\\-lindau\\ disease\\.\ \(0\)\
\-\ suggested\\ readings\\:\ \(0\)\
\-\ binkovitz\\,\\ l\\.a\\.\\,\\ johnson\\,\\ c\\.d\\.\\,\\ and\\ stephens\\,\\ d\\.h\\.\\ \\"islet\\ cell\\ tumors\\ in\\ von\\ hippel\\-lindau\\ disease\\:\\ increased\\ prevalence\\ and\\ relationship\\ to\\ the\\ multiple\\ endocrine\\ neoplasias\\.\\"\\.\\ ajr\\ 1990\\;155\\:501\\-505\\.\ \(0\)\
\-\ choyke\\,\\ p\\.l\\.\\,\\ glenn\\,\\ g\\.m\\.\\,\\ walther\\,\\ m\\.m\\.\\,\\ zbar\\,\\ b\\.\\,\\ weiss\\,\\ g\\.h\\.\\,\\ alexander\\,\\ r\\.b\\.\\,\\ and\\ hayes\\,\\ w\\.s\\.\\ \\"the\\ natural\\ history\\ of\\ renal\\ lesions\\ in\\ von\\ hippel\\-lindau\\ disease\\:\\ a\\ serial\\ ct\\ study\\ in\\ 28\\ patients\\.\\"\\.\\ ajr\\ 1992\\;159\\:1229\\-1234\\.\ \(0\)\
\-\ choyke\\,\\ p\\.l\\.\\,\\ glenn\\,\\ g\\.m\\.\\,\\ walther\\,\\ m\\.m\\.\\,\\ patronas\\,\\ n\\.j\\.\\,\\ linehan\\,\\ w\\.m\\.\\,\\ and\\ zbar\\,\\ b\\.\\ von\\ hippel\\-lindau\\ disease\\:\\ genetic\\,\\ clinical\\,\\ and\\ imaging\\ features\\.\\ radiology\\ 1995194\\:629\\-642\\.\\ \ \(0\)\
\-\ ho\\,\\ v\\.b\\.\\,\\ smirniotopoulos\\,\\ j\\.g\\.\\,\\ murphy\\,\\ f\\.m\\.\\,\\ and\\ rushing\\,\\ e\\.j\\.\\ radiologic\\-pathologic\\ correlation\\:\\ hemangioblastoma\\.\\ ajnr\\ am\\ j\\ neuroradiol\\ 1992\\;13\\(5\\)\\:1343\\-1352\\.\ \(0\)\
\-\ neumann\\,\\ h\\.\\ basic\\ criteria\\ for\\ clinical\\ diagnosis\\ and\\ genetic\\ counseling\\ in\\ von\\ hippel\\-lindau\\ syndrome\\.\\ vasa\\ 198716\\:220\\-226\ \(0\)\
\-\ tibbs\\ jr\\.\\,\\ r\\.e\\.\\,\\ bowles\\ jr\\.\\,\\ a\\.p\\.\\,\\ raila\\,\\ f\\.a\\.\\,\\ fratkin\\,\\ j\\.d\\.\\,\\ and\\ hutchins\\,\\ j\\.b\\.\\ should\\ endolymphatic\\ sac\\ tumors\\ be\\ considered\\ part\\ of\\ the\\ von\\ hippel\\-lindau\\ complex\\?\\ pathology\\ case\\ report\\.\\ neurosurg\\ 1997\\;40\\(4\\)\\:848\\-855\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ vhl\\:\\ 0\\.34650042530346986\ \(0\)\
\-\ lindau\\:\\ 0\\.32299742382811325\ \(0\)\
\-\ hippel\\:\\ 0\\.3208623150098927\ \(0\)\
\-\ von\\:\\ 0\\.3035221077161146\ \(0\)\
\-\ the\\:\\ 0\\.17312603017372477\ \(0\)\
\-\ and\\:\\ 0\\.16041522972614275\ \(0\)\
\-\ disease\\:\\ 0\\.15334960613771392\ \(0\)\
\-\ systemic\\:\\ 0\\.14183275465432826\ \(0\)\
\-\ hemangioblastomas\\:\\ 0\\.1313873039156487\ \(0\)\
\-\ lesions\\:\\ 0\\.13113070492538398\ \(0\)\
\-\ epididymal\\:\\ 0\\.1238622262782198\ \(0\)\
\-\ of\\:\\ 0\\.11617464453730757\ \(0\)\
\-\ masses\\:\\ 0\\.10880838599884742\ \(0\)\
\-\ pancreatic\\:\\ 0\\.10349455409710936\ \(0\)\
\-\ mutation\\:\\ 0\\.10270001668091543\ \(0\)\
\-\ cystadenomas\\:\\ 0\\.09635115887969034\ \(0\)\
\-\ iib\\:\\ 0\\.09450011599185541\ \(0\)\
\-\ may\\:\\ 0\\.09192101986564144\ \(0\)\
\-\ genetic\\:\\ 0\\.09007627830667135\ \(0\)\
\-\ patients\\:\\ 0\\.08991244157833936\ \(0\)\
\-\ chromosome\\:\\ 0\\.08706668705534105\ \(0\)\
\-\ bilateral\\:\\ 0\\.08589789548072874\ \(0\)\
\-\ renal\\:\\ 0\\.08531135205364618\ \(0\)\
\-\ gene\\:\\ 0\\.08021557875247318\ \(0\)\
\-\ in\\:\\ 0\\.07952043715823577\ \(0\)\
\-\ these\\:\\ 0\\.07736168453156325\ \(0\)\
\-\ choyke\\:\\ 0\\.07302887073781009\ \(0\)\
\-\ glenn\\:\\ 0\\.07302887073781009\ \(0\)\
\-\ zbar\\:\\ 0\\.07302887073781009\ \(0\)\
\-\ has\\:\\ 0\\.07300513926245707\ \(0\)\
\-\ walther\\:\\ 0\\.06978298471914365\ \(0\)\
\-\ cysts\\:\\ 0\\.06920785089415504\ \(0\)\
\-\ somatic\\:\\ 0\\.06747999193846\ \(0\)\
\-\ tumors\\:\\ 0\\.06716906016986411\ \(0\)\
\-\ develop\\:\\ 0\\.06305788608358977\ \(0\)\
\-\ is\\:\\ 0\\.06252886146234606\ \(0\)\
\-\ type\\:\\ 0\\.06126815517872799\ \(0\)\
\-\ iia\\:\\ 0\\.06098821990112712\ \(0\)\
\-\ dissemination\\:\\ 0\\.05938178277070231\ \(0\)\
\-\ angiomas\\:\\ 0\\.05868522712044346\ \(0\)\
\-\ islet\\:\\ 0\\.05689888713980781\ \(0\)\
\-\ retina\\:\\ 0\\.05638223433975981\ \(0\)\
\-\ epididymis\\:\\ 0\\.055896913634214875\ \(0\)\
\-\ multiple\\:\\ 0\\.05583981790779898\ \(0\)\
\-\ 1992\\:\\ 0\\.05459589435912415\ \(0\)\
\-\ retinal\\:\\ 0\\.05347705250164878\ \(0\)\
\-\ solid\\:\\ 0\\.05251401861514378\ \(0\)\
\-\ cell\\:\\ 0\\.052245393063159604\ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.051621401785651125\ \(0\)\
\-\ ajr\\:\\ 0\\.051087514662635995\ \(0\)\
\-\ prevalence\\:\\ 0\\.049890462302426934\ \(0\)\
\-\ presence\\:\\ 0\\.04921649912885508\ \(0\)\
\-\ with\\:\\ 0\\.04918017874834973\ \(0\)\
\-\ benign\\:\\ 0\\.047053542343405905\ \(0\)\
\-\ toxic\\:\\ 0\\.046644576283760494\ \(0\)\
\-\ inflammatory\\:\\ 0\\.04631780166615\ \(0\)\
\-\ be\\:\\ 0\\.046311539247090125\ \(0\)\
\-\ affecting\\:\\ 0\\.04593567623641207\ \(0\)\
\-\ as\\:\\ 0\\.04586350123887953\ \(0\)\
\-\ hemangioblastoma\\:\\ 0\\.04566880686024346\ \(0\)\
\-\ are\\:\\ 0\\.04331982928390817\ \(0\)\
\-\ pancreas\\:\\ 0\\.04291918528078297\ \(0\)\
\-\ suggested\\:\\ 0\\.042735146372652015\ \(0\)\
\-\ neoplasms\\:\\ 0\\.04255524352244119\ \(0\)\
\-\ anatomic\\:\\ 0\\.04237929490294859\ \(0\)\
\-\ adrenal\\:\\ 0\\.042292749844619455\ \(0\)\
\-\ suggests\\:\\ 0\\.04212241703730126\ \(0\)\
\-\ metabolic\\:\\ 0\\.04139782163884375\ \(0\)\
\-\ syndrome\\:\\ 0\\.04129482405289545\ \(0\)\
\-\ however\\:\\ 0\\.04054284136777944\ \(0\)\
\-\ or\\:\\ 0\\.03971542420353307\ \(0\)\
\-\ that\\:\\ 0\\.03963411759550172\ \(0\)\
\-\ both\\:\\ 0\\.03819788133150019\ \(0\)\
\-\ more\\:\\ 0\\.03761275997405166\ \(0\)\
\-\ suggest\\:\\ 0\\.037095810792477986\ \(0\)\
\-\ addition\\:\\ 0\\.036962013695931176\ \(0\)\
\-\ features\\:\\ 0\\.03674387104526936\ \(0\)\
\-\ infectious\\:\\ 0\\.03674387104526936\ \(0\)\
\-\ germline\\:\\ 0\\.03651443536890504\ \(0\)\
\-\ 3p\\:\\ 0\\.03651443536890504\ \(0\)\
\-\ subclassifying\\:\\ 0\\.03651443536890504\ \(0\)\
\-\ asynchronous\\:\\ 0\\.03651443536890504\ \(0\)\
\-\ maldevelopmental\\:\\ 0\\.03651443536890504\ \(0\)\
\-\ binkovitz\\:\\ 0\\.03651443536890504\ \(0\)\
\-\ hayes\\:\\ 0\\.03651443536890504\ \(0\)\
\-\ linehan\\:\\ 0\\.03651443536890504\ \(0\)\
\-\ without\\:\\ 0\\.03613015003018609\ \(0\)\
\-\ diagnosis\\:\\ 0\\.035508907540362004\ \(0\)\
\-\ complex\\:\\ 0\\.035184524285490924\ \(0\)\
\-\ it\\:\\ 0\\.03506319827650615\ \(0\)\
\-\ nonglial\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ metachronous\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ strikingly\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ readings\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ stephens\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ neoplasias\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ patronas\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ smirniotopoulos\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ rushing\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ neumann\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ tibbs\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ bowles\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ raila\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ fratkin\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ hutchins\\:\\ 0\\.03489149235957183\ \(0\)\
\-\ previous\\:\\ 0\\.034505699184952665\ \(0\)\
\-\ have\\:\\ 0\\.03421853697665198\ \(0\)\
\-\ classic\\:\\ 0\\.03415550920058161\ \(0\)\
\-\ racial\\:\\ 0\\.03373999596923\ \(0\)\
\-\ detachment\\:\\ 0\\.03373999596923\ \(0\)\
\-\ vasa\\:\\ 0\\.03373999596923\ \(0\)\
\-\ endolymphatic\\:\\ 0\\.03373999596923\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.033051578657076225\ \(0\)\
\-\ infratentorial\\:\\ 0\\.03284682597891218\ \(0\)\
\-\ alexander\\:\\ 0\\.03284682597891218\ \(0\)\
\-\ phakomatoses\\:\\ 0\\.03211705295989678\ \(0\)\
\-\ simultaneously\\:\\ 0\\.03211705295989678\ \(0\)\
\-\ weiss\\:\\ 0\\.03211705295989678\ \(0\)\
\-\ kidney\\:\\ 0\\.03208159456438564\ \(0\)\
\-\ clues\\:\\ 0\\.031500038663951804\ \(0\)\
\-\ johnson\\:\\ 0\\.031500038663951804\ \(0\)\
\-\ this\\:\\ 0\\.031382888168161004\ \(0\)\
\-\ neoplasm\\:\\ 0\\.03117350138757264\ \(0\)\
\-\ eca\\:\\ 0\\.03096555656955495\ \(0\)\
\-\ distributions\\:\\ 0\\.03049410995056356\ \(0\)\
\-\ neuroradiol\\:\\ 0\\.03049410995056356\ \(0\)\
\-\ study\\:\\ 0\\.03045551241814805\ \(0\)\
\-\ symmetry\\:\\ 0\\.030072386579237127\ \(0\)\
\-\ should\\:\\ 0\\.029796652163223896\ \(0\)\
\-\ further\\:\\ 0\\.029742622667290032\ \(0\)\
\-\ patient\\:\\ 0\\.029705305924672003\ \(0\)\
\-\ sexual\\:\\ 0\\.029690891385351154\ \(0\)\
\-\ will\\:\\ 0\\.029391454965595188\ \(0\)\
\-\ random\\:\\ 0\\.02902222901844702\ \(0\)\
\-\ ho\\:\\ 0\\.02902222901844702\ \(0\)\
\-\ clinical\\:\\ 0\\.02894056588270581\ \(0\)\
\-\ usually\\:\\ 0\\.028748043419593545\ \(0\)\
\-\ incompletely\\:\\ 0\\.028449443569903907\ \(0\)\
\-\ neurosurg\\:\\ 0\\.028449443569903907\ \(0\)\
\-\ create\\:\\ 0\\.027948456817107437\ \(0\)\
\-\ fit\\:\\ 0\\.027948456817107437\ \(0\)\
\-\ ajnr\\:\\ 0\\.027948456817107437\ \(0\)\
\-\ counseling\\:\\ 0\\.02771967055088851\ \(0\)\
\-\ cystic\\:\\ 0\\.027502699857726128\ \(0\)\
\-\ two\\:\\ 0\\.027118581747173937\ \(0\)\
\-\ subtypes\\:\\ 0\\.026916451985676104\ \(0\)\
\-\ rcc\\:\\ 0\\.026916451985676104\ \(0\)\
\-\ recur\\:\\ 0\\.026916451985676104\ \(0\)\
\-\ been\\:\\ 0\\.026605162774649735\ \(0\)\
\-\ people\\:\\ 0\\.026568174160546684\ \(0\)\
\-\ natural\\:\\ 0\\.026568174160546684\ \(0\)\
\-\ if\\:\\ 0\\.026532715765035544\ \(0\)\
\-\ predilection\\:\\ 0\\.026404777189244253\ \(0\)\
\-\ 1990\\:\\ 0\\.02624778961877197\ \(0\)\
\-\ responsible\\:\\ 0\\.026096727541555294\ \(0\)\
\-\ localization\\:\\ 0\\.026096727541555294\ \(0\)\
\-\ sporadic\\:\\ 0\\.025951159864601708\ \(0\)\
\-\ hematogenous\\:\\ 0\\.025951159864601708\ \(0\)\
\-\ evidence\\:\\ 0\\.025919733380422822\ \(0\)\
\-\ than\\:\\ 0\\.025886400896763934\ \(0\)\
\-\ together\\:\\ 0\\.025810700892825562\ \(0\)\
\-\ patterns\\:\\ 0\\.025675004170228857\ \(0\)\
\-\ basic\\:\\ 0\\.025675004170228857\ \(0\)\
\-\ autoimmune\\:\\ 0\\.025543757331317998\ \(0\)\
\-\ unlike\\:\\ 0\\.025416677770204853\ \(0\)\
\-\ divided\\:\\ 0\\.025416677770204853\ \(0\)\
\-\ recognized\\:\\ 0\\.02517401741743239\ \(0\)\
\-\ scrotum\\:\\ 0\\.02517401741743239\ \(0\)\
\-\ united\\:\\ 0\\.024945231151213467\ \(0\)\
\-\ actually\\:\\ 0\\.024945231151213467\ \(0\)\
\-\ murphy\\:\\ 0\\.024945231151213467\ \(0\)\
\-\ familial\\:\\ 0\\.024835562100209353\ \(0\)\
\-\ endocrine\\:\\ 0\\.024835562100209353\ \(0\)\
\-\ illustrates\\:\\ 0\\.024624846609438752\ \(0\)\
\-\ prone\\:\\ 0\\.02442467140115965\ \(0\)\
\-\ morphology\\:\\ 0\\.024328216855268488\ \(0\)\
\-\ into\\:\\ 0\\.02427492547557786\ \(0\)\
\-\ relationship\\:\\ 0\\.024234032040066536\ \(0\)\
\-\ scrotal\\:\\ 0\\.024142012586001058\ \(0\)\
\-\ hypervascular\\:\\ 0\\.024142012586001058\ \(0\)\
\-\ associated\\:\\ 0\\.02406907532063737\ \(0\)\
\-\ most\\:\\ 0\\.023765642248619948\ \(0\)\
\-\ cutaneous\\:\\ 0\\.023711202559323515\ \(0\)\
\-\ estimated\\:\\ 0\\.023711202559323515\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.023711202559323515\ \(0\)\
\-\ organs\\:\\ 0\\.02355107440809917\ \(0\)\
\-\ autosomal\\:\\ 0\\.02355107440809917\ \(0\)\
\-\ present\\:\\ 0\\.02343238539127879\ \(0\)\
\-\ shortly\\:\\ 0\\.023397106581235345\ \(0\)\
\-\ might\\:\\ 0\\.023322288141880247\ \(0\)\
\-\ originally\\:\\ 0\\.02324884259568323\ \(0\)\
\-\ far\\:\\ 0\\.02324884259568323\ \(0\)\
\-\ provide\\:\\ 0\\.023105874899310288\ \(0\)\
\-\ cystadenoma\\:\\ 0\\.023105874899310288\ \(0\)\
\-\ consideration\\:\\ 0\\.023036261493150512\ \(0\)\
\-\ case\\:\\ 0\\.02294178617577552\ \(0\)\
\-\ nih\\:\\ 0\\.022769317931642948\ \(0\)\
\-\ correlation\\:\\ 0\\.022769317931642948\ \(0\)\
\-\ criteria\\:\\ 0\\.022642238370529807\ \(0\)\
\-\ 1997\\:\\ 0\\.022580180228779098\ \(0\)\
\-\ findings\\:\\ 0\\.022537692584751103\ \(0\)\
\-\ etc\\:\\ 0\\.022458877916631134\ \(0\)\
\-\ every\\:\\ 0\\.02211558163534715\ \(0\)\
\-\ developing\\:\\ 0\\.021850407209763705\ \(0\)\
\-\ group\\:\\ 0\\.021699345132547024\ \(0\)\
\-\ always\\:\\ 0\\.02155377745559344\ \(0\)\
\-\ am\\:\\ 0\\.02155377745559344\ \(0\)\
\-\ half\\:\\ 0\\.021506408027439517\ \(0\)\
\-\ dominant\\:\\ 0\\.021367573186326008\ \(0\)\
\-\ neoplastic\\:\\ 0\\.021103565209814826\ \(0\)\
\-\ serial\\:\\ 0\\.02101929536119659\ \(0\)\
\-\ cerebellum\\:\\ 0\\.020977816544794803\ \(0\)\
\-\ diseases\\:\\ 0\\.020977816544794803\ \(0\)\
\-\ frequent\\:\\ 0\\.020936763159648465\ \(0\)\
\-\ resected\\:\\ 0\\.020896126567334618\ \(0\)\
\-\ somewhat\\:\\ 0\\.02077663500842412\ \(0\)\
\-\ pmh\\:\\ 0\\.020660607465275614\ \(0\)\
\-\ uncommon\\:\\ 0\\.020660607465275614\ \(0\)\
\-\ association\\:\\ 0\\.020547848742205197\ \(0\)\
\-\ asymmetric\\:\\ 0\\.020547848742205197\ \(0\)\
\-\ part\\:\\ 0\\.02040228106525161\ \(0\)\
\-\ sac\\:\\ 0\\.020331435499635238\ \(0\)\
\-\ 31\\:\\ 0\\.020261822093475466\ \(0\)\
\-\ rather\\:\\ 0\\.020227464200430485\ \(0\)\
\-\ states\\:\\ 0\\.02005996403044668\ \(0\)\
\-\ local\\:\\ 0\\.019654678751887374\ \(0\)\
\-\ symmetric\\:\\ 0\\.019566704442141074\ \(0\)\
\-\ report\\:\\ 0\\.019232955380560936\ \(0\)\
\-\ even\\:\\ 0\\.019206359469002003\ \(0\)\
\-\ so\\:\\ 0\\.019206359469002003\ \(0\)\
\-\ 28\\:\\ 0\\.0189496901461961\ \(0\)\
\-\ described\\:\\ 0\\.018525481416228395\ \(0\)\
\-\ site\\:\\ 0\\.018415208051799248\ \(0\)\
\-\ radiology\\:\\ 0\\.018286769118975588\ \(0\)\
\-\ located\\:\\ 0\\.018061495507622864\ \(0\)\
\-\ ii\\:\\ 0\\.018002195608749074\ \(0\)\
\-\ appear\\:\\ 0\\.01798262261149173\ \(0\)\
\-\ pathology\\:\\ 0\\.017924471419746825\ \(0\)\
\-\ considered\\:\\ 0\\.017791983250398612\ \(0\)\
\-\ additional\\:\\ 0\\.017699963796333134\ \(0\)\
\-\ vs\\:\\ 0\\.01741895931885594\ \(0\)\
\-\ specific\\:\\ 0\\.01730196272353876\ \(0\)\
\-\ at\\:\\ 0\\.01724838900167881\ \(0\)\
\-\ 13\\:\\ 0\\.01722043913229285\ \(0\)\
\-\ to\\:\\ 0\\.017124379838865895\ \(0\)\
\-\ about\\:\\ 0\\.017093359571179714\ \(0\)\
\-\ course\\:\\ 0\\.016865442034201993\ \(0\)\
\-\ 40\\:\\ 0\\.016792265042466028\ \(0\)\
\-\ metastasis\\:\\ 0\\.016734671675258737\ \(0\)\
\-\ could\\:\\ 0\\.016608038865634778\ \(0\)\
\-\ congenital\\:\\ 0\\.016405499709618365\ \(0\)\
\-\ risk\\:\\ 0\\.016314378084252262\ \(0\)\
\-\ they\\:\\ 0\\.016314378084252262\ \(0\)\
\-\ malignant\\:\\ 0\\.01627595215749301\ \(0\)\
\-\ identified\\:\\ 0\\.01618770074089187\ \(0\)\
\-\ typically\\:\\ 0\\.016028795264315263\ \(0\)\
\-\ was\\:\\ 0\\.015914834147820744\ \(0\)\
\-\ cause\\:\\ 0\\.015554686410464732\ \(0\)\
\-\ although\\:\\ 0\\.015544055142692487\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.015287056107947821\ \(0\)\
\-\ vascular\\:\\ 0\\.0150737883822102\ \(0\)\
\-\ body\\:\\ 0\\.01502686322620981\ \(0\)\
\-\ often\\:\\ 0\\.014898326081611948\ \(0\)\
\-\ differential\\:\\ 0\\.014835572971552668\ \(0\)\
\-\ resection\\:\\ 0\\.014636048656837592\ \(0\)\
\-\ show\\:\\ 0\\.014494714369980545\ \(0\)\
\-\ for\\:\\ 0\\.013840823696893911\ \(0\)\
\-\ infection\\:\\ 0\\.013792263436322009\ \(0\)\
\-\ on\\:\\ 0\\.013791726088677361\ \(0\)\
\-\ carcinoma\\:\\ 0\\.013657480669651906\ \(0\)\
\-\ high\\:\\ 0\\.012976602616878302\ \(0\)\
\-\ common\\:\\ 0\\.012948748155386705\ \(0\)\
\-\ abdominal\\:\\ 0\\.012487801563923238\ \(0\)\
\-\ increased\\:\\ 0\\.012346830796306673\ \(0\)\
\-\ surgery\\:\\ 0\\.012275817639258401\ \(0\)\
\-\ man\\:\\ 0\\.012087907383832735\ \(0\)\
\-\ imaging\\:\\ 0\\.011999349126319241\ \(0\)\
\-\ can\\:\\ 0\\.011981870190407588\ \(0\)\
\-\ tumor\\:\\ 0\\.01194281944199846\ \(0\)\
\-\ had\\:\\ 0\\.01137608358755568\ \(0\)\
\-\ but\\:\\ 0\\.01129079883348889\ \(0\)\
\-\ well\\:\\ 0\\.011055699045780968\ \(0\)\
\-\ also\\:\\ 0\\.010739841056251432\ \(0\)\
\-\ within\\:\\ 0\\.010516031025420298\ \(0\)\
\-\ by\\:\\ 0\\.009696082649443254\ \(0\)\
\-\ there\\:\\ 0\\.009085054840284702\ \(0\)\
\-\ not\\:\\ 0\\.009013801242069432\ \(0\)\
\-\ history\\:\\ 0\\.00872340779655592\ \(0\)\
\-\ ct\\:\\ 0\\.008692617875783883\ \(0\)\
